Publication | Closed Access

Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary

Antipsychotic-induced HyperprolactinemiaMolecular PharmacologyDopamine D2 ReceptorPsychiatryMedicinePsychotropic MedicationNeuroendocrinologyPsychopharmacologyHypothalamic PeptideNeuropharmacologyNeuroscienceDopamineEndocrinologyPharmacologySocial Sciences